GlaxoSmithKline cell therapy lead leaves for partner; Ferring and Igenomix create Boston hub for maternal health
→ GlaxoSmithKline is losing its cell therapy R&D chief to a partner. Immatics hired Cedrik Britten, who had been head …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
